6 years ago

Rinri Therapeutics Raises £1.4M in Seed Funding

  • Rinri Therapeutics, a UK biotech company, has secured £1.4m in seed funding co-led by Boehringer Ingelheim Venture Fund and UCB Ventures

  • The funds will support ongoing growth.

      • ProblemHealthcare

      "restoring hearing after neuropathic sensorineural hearing loss (SNHL) through repairing damaged cytoarchitecture in the inner ear"

      Solution

      "developing stem cell-based therapeutics, a novel cell-based therapy, to reverse SNHL"

      Covered on